;Ligand name;Target name;targetSpecies;primaryTarget;type;action;pKi
487;cetirizine;H1 receptor;Human;TRUE;Antagonist;Inverse agonist;8.5
1107;17beta-estradiol;GPER;Human;FALSE;Agonist;Full agonist;8.2 - 8.5
780;abarelix;GnRH1 receptor;Human;TRUE;Antagonist;Antagonist;9.1 - 9.5
1056;acebutolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.4
198;ACTH;MC1 receptor;Human;FALSE;Agonist;Agonist;8.6
199;ACTH;MC3 receptor;Human;FALSE;Agonist;Agonist;7.1
200;ACTH;MC4 receptor;Human;FALSE;Agonist;Agonist;6.2
201;ACTH;MC5 receptor;Human;FALSE;Agonist;Agonist;5.0
692;adenosine;A1 receptor;Human;TRUE;Agonist;Agonist;7.0
694;adenosine;A2A receptor;Human;FALSE;Agonist;Agonist;6.5
696;adenosine;A2B receptor;Human;FALSE;Agonist;Agonist;4.8
698;adenosine;A3 receptor;Human;FALSE;Agonist;Agonist;6.5
1112;adomeglivant;glucagon receptor;Human;FALSE;Antagonist;Antagonist;8.2
367;adrenaline;alpha1A-adrenoceptor;Human;FALSE;Agonist;Full agonist;6.3 - 6.5
374;adrenaline;alpha1B-adrenoceptor;Human;FALSE;Agonist;Full agonist;6.5
379;adrenaline;alpha1D-adrenoceptor;Human;TRUE;Agonist;Full agonist;7.2
388;adrenaline;alpha2A-adrenoceptor;Human;TRUE;Agonist;Full agonist;5.8 - 7.4
395;adrenaline;alpha2B-adrenoceptor;Human;FALSE;Agonist;Agonist;5.2
402;adrenaline;alpha2C-adrenoceptor;Human;FALSE;Agonist;Agonist;5.8
410;adrenaline;beta1-adrenoceptor;Human;FALSE;Agonist;Agonist;5.4 - 6.0
416;adrenaline;beta2-adrenoceptor;Human;FALSE;Agonist;Full agonist;6.0 - 6.2
421;adrenaline;beta3-adrenoceptor;Human;FALSE;Agonist;Agonist;3.9
493;afamelanotide;MC3 receptor;Human;FALSE;Agonist;Full agonist;8.9
494;afamelanotide;MC4 receptor;Human;FALSE;Agonist;Full agonist;8.5 - 8.8
24;agomelatine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;5.4
33;agomelatine;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;6.6
40;agomelatine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;6.2
202;agomelatine;MT1 receptor;Human;TRUE;Agonist;Full agonist;10.0 - 10.4
204;agomelatine;MT2 receptor;Human;TRUE;Agonist;Full agonist;9.9 - 10.5
702;alfuzosin;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.1
705;alfuzosin;alpha1B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.6
708;alfuzosin;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.4
190;alimemazine;H1 receptor;Bovine;FALSE;Antagonist;Antagonist;9.1
420;alprenolol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.0
1136;alvimopan;delta receptor;Human;FALSE;Antagonist;Antagonist;7.9
1145;alvimopan;kappa receptor;Human;FALSE;Antagonist;Antagonist;7.0
1159;alvimopan;mu receptor;Human;TRUE;Antagonist;Antagonist;9.3
161;amisulpride;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.9 - 8.0
162;amisulpride;D2 receptor;Human;FALSE;Antagonist;Antagonist;7.8
170;amisulpride;D3 receptor;Rat;FALSE;Antagonist;Antagonist;7.4
271;amitriptyline;5-HT2A receptor;Rat;FALSE;Antagonist;Antagonist;8.0
272;amitriptyline;5-HT2A receptor;Rat;FALSE;Antagonist;Antagonist;8.4
288;amitriptyline;5-HT2C receptor;Rat;FALSE;Antagonist;Antagonist;8.1
295;amitriptyline;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;6.9 - 7.2
308;amitriptyline;5-HT7 receptor;Mouse;FALSE;Antagonist;Antagonist;6.4
310;amitriptyline;5-HT7 receptor;Rat;FALSE;Antagonist;Antagonist;6.9 - 7.0
479;amitriptyline;H1 receptor;Human;TRUE;Antagonist;Antagonist;9.3
320;amitriptyline;M1 receptor;Human;TRUE;Antagonist;Antagonist;7.8
328;amitriptyline;M2 receptor;Human;TRUE;Antagonist;Antagonist;7.9
335;amitriptyline;M3 receptor;Human;TRUE;Antagonist;Antagonist;7.9
341;amitriptyline;M4 receptor;Human;TRUE;Antagonist;Antagonist;8.1
346;amitriptyline;M5 receptor;Human;TRUE;Antagonist;Antagonist;7.8
913;amoxapine;5-HT2A receptor;Rat;FALSE;Antagonist;Antagonist;9.0
936;amoxapine;5-HT2C receptor;Rat;FALSE;Antagonist;Antagonist;8.7
951;amoxapine;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;7.3
973;amoxapine;5-HT7 receptor;Rat;FALSE;Antagonist;Antagonist;7.4
553;apomorphine;5-HT1A receptor;Human;FALSE;Agonist;Partial agonist;6.9
589;apomorphine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;6.9
601;apomorphine;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;6.9
609;apomorphine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;7.0
711;apomorphine;alpha2A-adrenoceptor;Human;FALSE;Agonist;Partial agonist;6.9
715;apomorphine;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.2
720;apomorphine;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
733;apomorphine;D1 receptor;Human;FALSE;Agonist;Full agonist;5.3 - 6.2
739;apomorphine;D2 receptor;Human;TRUE;Agonist;Partial agonist;5.7 - 7.5
753;apomorphine;D3 receptor;Human;TRUE;Agonist;Partial agonist;6.1 - 7.6
764;apomorphine;D4 receptor;Human;TRUE;Agonist;Partial agonist;8.4
773;apomorphine;D5 receptor;Human;FALSE;Agonist;Partial agonist;6.4 - 7.8
387;apraclonidine;alpha2A-adrenoceptor;Human;TRUE;Agonist;Agonist;8.5
403;apraclonidine;alpha2C-adrenoceptor;Human;TRUE;Agonist;Agonist;7.5
539;aprepitant;NK1 receptor;Human;TRUE;Antagonist;Antagonist;10.1
723;arformoterol;beta1-adrenoceptor;Human;FALSE;Agonist;Agonist;6.5
727;arformoterol;beta2-adrenoceptor;Human;TRUE;Agonist;Agonist;8.6
851;aripiprazole;5-HT1A receptor;Human;FALSE;Agonist;Partial agonist;8.2
862;aripiprazole;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;6.1
871;aripiprazole;5-HT1D receptor;Human;FALSE;Agonist;Full agonist;7.2
897;aripiprazole;5-HT2A receptor;Human;FALSE;Agonist;Partial agonist;7.5 - 8.1
930;aripiprazole;5-HT2C receptor;Human;FALSE;Agonist;Partial agonist;7.6
954;aripiprazole;5-HT6 receptor;Rat;FALSE;Antagonist;Antagonist;6.8
964;aripiprazole;5-HT7 receptor;Rat;FALSE;Agonist;Partial agonist;7.8
1081;aripiprazole;D2 receptor;Human;TRUE;Agonist;Partial agonist;9.1
1104;aripiprazole;D4 receptor;Rat;FALSE;Antagonist;Antagonist;7.3
1114;aripiprazole;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.5
232;asenapine;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;8.0 - 8.3
241;asenapine;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;8.1
249;asenapine;5-HT1D receptor;Human;FALSE;Agonist;Full agonist;8.4
256;asenapine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;8.0
265;asenapine;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;10.2
438;asenapine;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.9
476;asenapine;H1 receptor;Human;FALSE;Antagonist;Antagonist;9.8
185;astemizole;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.5
126;atenolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.7 - 7.6
132;atenolol;beta2-adrenoceptor;Human;FALSE;Antagonist;Antagonist;5.6 - 6.0
549;atosiban;OT receptor;Human;FALSE;Antagonist;Antagonist;6.0 - 7.6
541;atosiban;V1A receptor;Human;FALSE;Antagonist;Antagonist;8.3 - 8.5
544;atosiban;V1B receptor;Human;FALSE;Antagonist;Antagonist;6.2 - 6.6
545;atosiban;V2 receptor;Human;FALSE;Antagonist;Antagonist;5.5 - 6.0
980;atropine;M1 receptor;Human;TRUE;Antagonist;Antagonist;8.5 - 9.6
986;atropine;M2 receptor;Human;TRUE;Antagonist;Antagonist;7.8 - 9.2
993;atropine;M3 receptor;Human;TRUE;Antagonist;Antagonist;8.9 - 9.8
998;atropine;M4 receptor;Human;FALSE;Antagonist;Antagonist;8.7 - 9.5
1002;atropine;M5 receptor;Human;FALSE;Antagonist;Antagonist;9.3 - 9.7
186;azelastine;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.9
473;baclofen;GABAB receptor;Human;TRUE;Agonist;Full agonist;4.3 - 6.2
1091;benperidol;D2 receptor;Human;FALSE;Antagonist;Antagonist;10.6
1103;benperidol;D4 receptor;Human;FALSE;Antagonist;Antagonist;10.2
661;benzatropine;M1 receptor;Rat;FALSE;Antagonist;Antagonist;9.0
671;benzatropine;M2 receptor;Rat;FALSE;Antagonist;Antagonist;8.6
435;benzquinamide;D2 receptor;Human;TRUE;Agonist;Agonist;5.4
1052;betaxolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.8
1060;betaxolol;beta2-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.2
652;bethanechol;M1 receptor;Human;FALSE;Agonist;Full agonist;4.0
664;bethanechol;M2 receptor;Human;TRUE;Agonist;Full agonist;4.0
673;bethanechol;M3 receptor;Human;TRUE;Agonist;Full agonist;4.2
683;bethanechol;M4 receptor;Human;FALSE;Agonist;Full agonist;4.0
269;blonanserin;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;9.1
446;blonanserin;D2 receptor;Human;TRUE;Antagonist;Antagonist;9.9
1106;bosentan;ETB receptor;Human;TRUE;Antagonist;Antagonist;7.1
741;brexpiprazole;D2 receptor;Human;FALSE;Agonist;Partial agonist;9.5
389;brimonidine;alpha2A-adrenoceptor;Human;TRUE;Agonist;Full agonist;6.7 - 8.7
397;brimonidine;alpha2B-adrenoceptor;Human;TRUE;Agonist;Partial agonist;6.0 - 8.3
405;brimonidine;alpha2C-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.7 - 7.6
554;bromocriptine;5-HT1A receptor;Human;FALSE;Agonist;Partial agonist;7.9
565;bromocriptine;5-HT1B receptor;Human;FALSE;Agonist;Partial agonist;6.5
572;bromocriptine;5-HT1D receptor;Human;FALSE;Agonist;Partial agonist;8.0
587;bromocriptine;5-HT2A receptor;Human;FALSE;Agonist;Partial agonist;7.0
602;bromocriptine;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;7.3
607;bromocriptine;5-HT2C receptor;Human;FALSE;Agonist;Partial agonist;6.1
621;bromocriptine;5-HT6 receptor;Human;FALSE;Agonist;Full agonist;7.5
634;bromocriptine;5-HT7 receptor;Rat;FALSE;Agonist;Full agonist;7.3 - 8.0
712;bromocriptine;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.0
716;bromocriptine;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.5
721;bromocriptine;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.6
734;bromocriptine;D1 receptor;Human;FALSE;Agonist;Partial agonist;6.2
738;bromocriptine;D2 receptor;Human;TRUE;Agonist;Full agonist;7.3 - 8.3
754;bromocriptine;D3 receptor;Human;TRUE;Agonist;Partial agonist;7.1 - 8.2
766;bromocriptine;D4 receptor;Human;TRUE;Antagonist;Antagonist;6.4
772;bromocriptine;D5 receptor;Human;FALSE;Agonist;Full agonist;6.3
413;bupranolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;7.3 - 9.0
419;bupranolol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.3 - 9.1
425;bupranolol;beta3-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.8 - 7.3
1144;buprenorphine;kappa receptor;Human;TRUE;Antagonist;Antagonist;9.1 - 10.2
1156;buprenorphine;mu receptor;Human;TRUE;Agonist;Partial agonist;8.8
779;buserelin;GnRH1 receptor;Human;FALSE;Agonist;Full agonist;9.4 - 10.0
555;buspirone;5-HT1A receptor;Human;TRUE;Agonist;Partial agonist;7.7 - 8.0
636;buspirone;5-HT7 receptor;Rat;FALSE;Agonist;Partial agonist;6.4
641;buspirone;5-HT7 receptor;Mouse;FALSE;Antagonist;Antagonist;6.4
500;butorphanol;kappa receptor;Human;TRUE;Agonist;Partial agonist;9.9
503;butorphanol;mu receptor;Human;TRUE;Agonist;Partial agonist;9.9
233;cabergoline;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;7.7
242;cabergoline;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;6.3
253;cabergoline;5-HT1D receptor;Human;FALSE;Agonist;Partial agonist;8.1
263;cabergoline;5-HT2A receptor;Human;FALSE;Agonist;Full agonist;8.2
278;cabergoline;5-HT2B receptor;Human;FALSE;Agonist;Full agonist;8.9
283;cabergoline;5-HT2C receptor;Human;FALSE;Agonist;Full agonist;6.2
368;cabergoline;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.5
391;cabergoline;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.9
398;cabergoline;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.1
406;cabergoline;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.7
428;cabergoline;D1 receptor;Human;FALSE;Agonist;Full agonist;6.7
437;cabergoline;D2 receptor;Human;TRUE;Agonist;Partial agonist;9.0 - 9.2
449;cabergoline;D3 receptor;Human;FALSE;Agonist;Partial agonist;9.1
458;cabergoline;D4 receptor;Human;FALSE;Agonist;Partial agonist;7.3
464;cabergoline;D5 receptor;Human;FALSE;Agonist;Full agonist;7.7
350;caffeine;A1 receptor;Human;TRUE;Antagonist;Antagonist;4.3 - 5.0
355;caffeine;A2A receptor;Human;TRUE;Antagonist;Antagonist;4.6 - 5.6
360;caffeine;A2B receptor;Human;TRUE;Antagonist;Antagonist;4.5 - 5.0
364;caffeine;A3 receptor;Human;TRUE;Antagonist;Antagonist;4.9
1071;calcitonin (salmon);AMY1 receptor;Rat;FALSE;Agonist;Full agonist;9.0
1072;calcitonin (salmon);AMY3 receptor;Rat;FALSE;Agonist;Full agonist;8.2
1063;carazolol;beta2-adrenoceptor;Human;FALSE;Antagonist;Antagonist;9.9
1065;carazolol;beta3-adrenoceptor;Human;FALSE;Agonist;Full agonist;8.7
653;carbachol;M1 receptor;Human;FALSE;Agonist;Full agonist;3.2 - 5.3
665;carbachol;M2 receptor;Human;FALSE;Agonist;Full agonist;4.2 - 5.7
674;carbachol;M3 receptor;Human;TRUE;Agonist;Full agonist;4.0 - 4.4
684;carbachol;M4 receptor;Human;FALSE;Agonist;Full agonist;4.3 - 4.9
688;carbachol;M5 receptor;Human;FALSE;Agonist;Full agonist;4.9
1082;cariprazine;D2 receptor;Human;FALSE;Agonist;Partial agonist;8.2
1095;cariprazine;D3 receptor;Human;FALSE;Agonist;Partial agonist;10.1
1053;carvedilol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.5
1061;carvedilol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.4 - 9.9
488;cetirizine;H1 receptor;Human;TRUE;Antagonist;Inverse agonist;8.2
181;cetrorelix;GnRH1 receptor;Human;TRUE;Antagonist;Antagonist;9.3 - 10.0
651;cevimeline;M1 receptor;Human;FALSE;Agonist;Agonist;5.3
662;cevimeline;M2 receptor;Human;FALSE;Agonist;Agonist;6.1
672;cevimeline;M3 receptor;Human;FALSE;Agonist;Agonist;5.6
681;cevimeline;M4 receptor;Human;FALSE;Agonist;Agonist;6.0
1108;chenodeoxycholic acid;FPR1;Human;FALSE;Antagonist;Antagonist;4.0
222;chlordiazepoxide;TRH1 receptor;Mouse;FALSE;Antagonist;Antagonist;4.7
223;chlordiazepoxide;TRH1 receptor;Rat;FALSE;Antagonist;Antagonist;4.8
787;chlorpheniramine;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.1
238;chlorpromazine;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;6.2
274;chlorpromazine;5-HT2A receptor;Human;TRUE;Antagonist;Inverse agonist;8.1
285;chlorpromazine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;7.6 - 8.2
298;chlorpromazine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;7.7 - 7.8
313;chlorpromazine;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;7.6
392;chlorpromazine;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;5.9 - 6.6
399;chlorpromazine;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.2 - 8.3
407;chlorpromazine;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.9 - 7.4
431;chlorpromazine;D1 receptor;Human;FALSE;Antagonist;Antagonist;7.1
440;chlorpromazine;D2 receptor;Human;FALSE;Antagonist;Antagonist;7.0 - 7.6
452;chlorpromazine;D3 receptor;Human;FALSE;Antagonist;Antagonist;7.2 - 7.5
461;chlorpromazine;D4 receptor;Human;FALSE;Antagonist;Antagonist;7.8
467;chlorpromazine;D5 receptor;Human;FALSE;Antagonist;Antagonist;6.9
478;chlorpromazine;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.2
789;cimetidine;H2 receptor;Human;TRUE;Antagonist;Antagonist;6.8
1131;cinacalcet;mGlu5 receptor;Rat;FALSE;Allosteric modulator;Positive;4.3
944;cisapride;5-HT4 receptor;Human;TRUE;Agonist;Partial agonist;6.4 - 7.4
963;cisapride;5-HT7 receptor;Mouse;FALSE;Agonist;Full agonist;5.8
1125;clemastine;H1 receptor;Human;TRUE;Antagonist;Antagonist;10.3
677;clidinium;M3 receptor;Human;TRUE;Antagonist;Antagonist;9.6
106;clonidine;alpha1D-adrenoceptor;Rat;FALSE;Agonist;Full agonist;6.9
113;clonidine;alpha2A-adrenoceptor;Human;TRUE;Agonist;Partial agonist;7.2 - 9.2
118;clonidine;alpha2B-adrenoceptor;Human;TRUE;Agonist;Partial agonist;6.7 - 9.5
123;clonidine;alpha2C-adrenoceptor;Human;FALSE;Agonist;Partial agonist;6.0 - 7.8
234;clozapine;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;6.8 - 6.9
243;clozapine;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;6.2
250;clozapine;5-HT1D receptor;Human;FALSE;Agonist;Full agonist;6.4
257;clozapine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;6.4
260;clozapine;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;6.9
273;clozapine;5-HT2A receptor;Human;TRUE;Antagonist;Inverse agonist;7.6 - 9.0
280;clozapine;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;8.0 - 8.8
289;clozapine;5-HT2C receptor;Human;FALSE;Antagonist;Inverse agonist;7.4 - 8.7
291;clozapine;5-HT5A receptor;Human;FALSE;Antagonist;Antagonist;6.0 - 6.5
297;clozapine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;7.8 - 8.1
312;clozapine;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;7.2 - 7.8
369;clozapine;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.1
375;clozapine;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.2
382;clozapine;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.7
430;clozapine;D1 receptor;Human;FALSE;Antagonist;Antagonist;6.9
439;clozapine;D2 receptor;Human;TRUE;Antagonist;Antagonist;5.8 - 6.9
451;clozapine;D3 receptor;Human;FALSE;Antagonist;Antagonist;5.2 - 6.3
460;clozapine;D4 receptor;Human;FALSE;Antagonist;Antagonist;7.5
466;clozapine;D5 receptor;Human;FALSE;Antagonist;Antagonist;6.6
477;clozapine;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.8 - 9.6
489;clozapine;H3 receptor;Rat;FALSE;Antagonist;Antagonist;5.8
490;clozapine;H4 receptor;Human;FALSE;Antagonist;Antagonist;6.2 - 6.7
1152;codeine;mu receptor;Human;TRUE;Agonist;Full agonist;6.9
1193;conivaptan;V1A receptor;Human;TRUE;Antagonist;Antagonist;8.2 - 8.4
1194;conivaptan;V2 receptor;Human;TRUE;Antagonist;Antagonist;9.4
380;corbadrine;alpha1D-adrenoceptor;Human;FALSE;Agonist;Full agonist;5.6
1126;cyclizine;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.4
952;cyproheptadine;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;6.8
967;cyproheptadine;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;6.9
1014;cyproheptadine;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
1022;cyproheptadine;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.6
1031;cyproheptadine;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.9
1121;cyproheptadine;H1 receptor;Human;TRUE;Antagonist;Antagonist;10.2
385;dapiprazole;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.4
981;darifenacin;M1 receptor;Human;FALSE;Antagonist;Antagonist;7.5 - 8.3
991;darifenacin;M2 receptor;Human;FALSE;Antagonist;Inverse agonist;7.0 - 7.6
994;darifenacin;M3 receptor;Human;TRUE;Antagonist;Antagonist;8.6 - 9.1
999;darifenacin;M4 receptor;Human;FALSE;Antagonist;Antagonist;7.3 - 8.1
1003;darifenacin;M5 receptor;Human;FALSE;Antagonist;Antagonist;7.9 - 8.6
1113;degarelix;GnRH1 receptor;Human;TRUE;Antagonist;Antagonist;8.8
1074;delta<sup>9</sup>-tetrahydrocannabinol;CB1 receptor;Human;TRUE;Agonist;Partial agonist;7.3 - 7.4
1076;delta<sup>9</sup>-tetrahydrocannabinol;CB2 receptor;Human;FALSE;Agonist;Partial agonist;7.1 - 7.5
776;deoxycholic acid;FPR1;Human;FALSE;Antagonist;Antagonist;4.0
187;desloratadine;H1 receptor;Human;TRUE;Antagonist;Antagonist;9.0
845;desmopressin;OT receptor;Human;FALSE;Agonist;Full agonist;6.7 - 7.6
835;desmopressin;V1A receptor;Human;FALSE;Agonist;Full agonist;7.0 - 7.7
839;desmopressin;V1B receptor;Human;FALSE;Agonist;Full agonist;7.7 - 8.2
843;desmopressin;V2 receptor;Human;FALSE;Agonist;Full agonist;7.2 - 8.6
330;dexetimide;M2 receptor;Human;TRUE;Antagonist;Antagonist;8.9
114;dexmedetomidine;alpha2A-adrenoceptor;Human;TRUE;Agonist;Partial agonist;7.6 - 9.6
116;dexmedetomidine;alpha2B-adrenoceptor;Human;TRUE;Agonist;Full agonist;7.5 - 9.7
121;dexmedetomidine;alpha2C-adrenoceptor;Human;TRUE;Agonist;Full agonist;7.0 - 9.3
833;diazepam;TRH1 receptor;Rat;FALSE;Antagonist;Antagonist;5.2
983;dicyclomine;M1 receptor;Human;TRUE;Antagonist;Antagonist;9.1
988;dicyclomine;M2 receptor;Human;FALSE;Antagonist;Antagonist;6.6
996;dicyclomine;M3 receptor;Human;TRUE;Antagonist;Antagonist;9.0
564;dihydroergotamine;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;8.0 - 9.2
571;dihydroergotamine;5-HT1D receptor;Human;TRUE;Agonist;Full agonist;9.2 - 9.9
579;dihydroergotamine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;5.6
584;dihydroergotamine;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;6.6 - 7.1
629;dihydroergotamine;5-HT6 receptor;Rat;FALSE;Antagonist;Antagonist;7.9 - 8.3
640;dihydroergotamine;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;8.0
1122;diphenhydramine;H1 receptor;Human;TRUE;Antagonist;Antagonist;7.9
125;dobutamine;beta1-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.5
1088;domperidone;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.9 - 8.4
1098;domperidone;D3 receptor;Human;TRUE;Antagonist;Antagonist;7.1 - 7.6
150;dopamine;D1 receptor;Human;TRUE;Agonist;Full agonist;4.3 - 5.6
154;dopamine;D2 receptor;Human;TRUE;Agonist;Full agonist;4.7 - 7.2
166;dopamine;D3 receptor;Human;TRUE;Agonist;Full agonist;6.4 - 7.3
172;dopamine;D4 receptor;Human;TRUE;Agonist;Full agonist;7.6
176;dopamine;D5 receptor;Human;TRUE;Agonist;Full agonist;6.6
485;dosulepin;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.4
324;dosulepin;M1 receptor;Human;FALSE;Antagonist;Antagonist;7.7
333;dosulepin;M2 receptor;Human;FALSE;Antagonist;Antagonist;7.0
340;dosulepin;M3 receptor;Human;FALSE;Antagonist;Antagonist;7.4
345;dosulepin;M4 receptor;Human;FALSE;Antagonist;Antagonist;7.2
349;dosulepin;M5 receptor;Human;FALSE;Antagonist;Antagonist;7.0
100;doxazosin;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.3
103;doxazosin;alpha1B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.1
110;doxazosin;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.1
483;doxepin;H1 receptor;Human;FALSE;Antagonist;Antagonist;9.5 - 10.0
25;duloxetine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;6.3
41;duloxetine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;6.0
54;duloxetine;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;6.4
182;elagolix;GnRH1 receptor;Human;TRUE;Antagonist;Antagonist;9.1
848;eletriptan;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;7.4
863;eletriptan;5-HT1B receptor;Human;TRUE;Agonist;Full agonist;8.0
872;eletriptan;5-HT1D receptor;Human;TRUE;Agonist;Full agonist;8.9
878;eletriptan;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;7.2
886;eletriptan;5-HT1F receptor;Human;TRUE;Agonist;Full agonist;8.0
1138;eluxadoline;delta receptor;Rat;FALSE;Antagonist;Antagonist;8.9
1147;eluxadoline;mu receptor;Human;FALSE;Agonist;Agonist;8.8
728;ephedrine;beta2-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.6
1073;erenumab;CGRP receptor;Human;TRUE;Antibody;Antagonist;10.7
882;ergometrine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;7.3
895;ergometrine;5-HT2A receptor;Rat;FALSE;Agonist;Full agonist;8.5
7;ergotamine;5-HT1D receptor;Human;TRUE;Agonist;Agonist;9.1
13;ergotamine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;6.2 - 6.3
16;ergotamine;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;6.8
19;ergotamine;5-HT2A receptor;Human;FALSE;Agonist;Partial agonist;9.0
30;ergotamine;5-HT2B receptor;Human;FALSE;Agonist;Partial agonist;8.5 - 8.9
35;ergotamine;5-HT2C receptor;Human;FALSE;Agonist;Partial agonist;8.7
46;ergotamine;5-HT5A receptor;Human;FALSE;Antagonist;Antagonist;8.0 - 8.7
51;ergotamine;5-HT6 receptor;Human;FALSE;Agonist;Full agonist;8.0 - 8.6
61;ergotamine;5-HT7 receptor;Mouse;FALSE;Antagonist;Antagonist;7.3
724;esmolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.9
985;ethopropazine;M1 receptor;Rat;FALSE;Antagonist;Antagonist;8.5
990;ethopropazine;M2 receptor;Rat;FALSE;Antagonist;Antagonist;8.1
1111;exendin-4;GLP-1 receptor;Human;TRUE;Agonist;Full agonist;8.7 - 9.0
1077;fenoldopam;D1 receptor;Human;TRUE;Agonist;Full agonist;6.5 - 7.9
1102;fenoldopam;D4 receptor;Human;FALSE;Agonist;Full agonist;6.5
414;fenoterol;beta2-adrenoceptor;Human;TRUE;Agonist;Agonist;6.9
1133;fentanyl;delta receptor;Human;FALSE;Agonist;Full agonist;6.8
1140;fentanyl;kappa receptor;Human;FALSE;Agonist;Partial agonist;7.1
1150;fentanyl;mu receptor;Human;TRUE;Agonist;Full agonist;9.2
786;fexofenadine;H1 receptor;Human;TRUE;Antagonist;Antagonist;7.6
847;flibanserin;5-HT1A receptor;Human;TRUE;Agonist;Agonist;9.0
910;flibanserin;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.3
914;fluoxetine;5-HT2A receptor;Rat;FALSE;Antagonist;Antagonist;6.5
922;fluoxetine;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;5.3
937;fluoxetine;5-HT2C receptor;Rat;FALSE;Antagonist;Antagonist;7.3
958;fluoxetine;5-HT6 receptor;Rat;FALSE;Antagonist;Antagonist;5.8
434;flupentixol;D1 receptor;Human;TRUE;Antagonist;Antagonist;7.0 - 8.4
444;flupentixol;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.8
454;flupentixol;D3 receptor;Human;FALSE;Antagonist;Antagonist;9.0
470;flupentixol;D5 receptor;Human;FALSE;Antagonist;Antagonist;8.1
267;fluphenazine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;7.5
299;fluphenazine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;7.3 - 7.4
314;fluphenazine;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;7.9
433;fluphenazine;D1 receptor;Human;FALSE;Antagonist;Antagonist;7.7
441;fluphenazine;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.8
469;fluphenazine;D5 receptor;Human;FALSE;Antagonist;Antagonist;7.9
480;fluphenazine;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.7
557;fluspirilene;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;7.2
574;fluspirilene;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;6.0
580;fluspirilene;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;5.6
590;fluspirilene;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;8.0
781;fluspirilene;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.9
231;frovatriptan;5-HT1A receptor;Human;FALSE;Agonist;Agonist;7.2
240;frovatriptan;5-HT1B receptor;Human;TRUE;Agonist;Agonist;8.0
248;frovatriptan;5-HT1D receptor;Human;TRUE;Agonist;Agonist;8.4
471;fulvestrant;GPER;Human;FALSE;Agonist;Full agonist;7.0
326;gallamine;M2 receptor;Human;FALSE;Allosteric modulator;Negative;5.8 - 7.6
180;glucagon;GLP-1 receptor;Human;FALSE;Agonist;Full agonist;6.9 - 7.0
1035;guanfacine;alpha2A-adrenoceptor;Human;TRUE;Agonist;Partial agonist;7.1 - 7.3
1040;guanfacine;alpha2B-adrenoceptor;Human;TRUE;Agonist;Full agonist;5.8 - 6.5
1045;guanfacine;alpha2C-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.4 - 6.2
558;haloperidol;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;5.7 - 5.8
575;haloperidol;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;6.6
591;haloperidol;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;6.7 - 7.3
604;haloperidol;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;5.8 - 6.4
638;haloperidol;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;6.3 - 6.6
736;haloperidol;D1 receptor;Human;FALSE;Antagonist;Antagonist;7.6 - 8.2
744;haloperidol;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.4 - 8.8
757;haloperidol;D3 receptor;Human;TRUE;Antagonist;Antagonist;7.5 - 8.6
767;haloperidol;D4 receptor;Human;TRUE;Antagonist;Antagonist;8.7 - 8.8
775;haloperidol;D5 receptor;Human;FALSE;Antagonist;Antagonist;6.3
782;haloperidol;H1 receptor;Human;FALSE;Antagonist;Antagonist;5.7 - 6.1
208;hydrocodone;kappa receptor;Human;FALSE;Agonist;Agonist;6.6
211;hydrocodone;mu receptor;Human;TRUE;Agonist;Agonist;8.7
496;hydromorphone;delta receptor;Human;FALSE;Agonist;Agonist;7.4
498;hydromorphone;kappa receptor;Human;FALSE;Agonist;Agonist;8.6
502;hydromorphone;mu receptor;Human;TRUE;Agonist;Agonist;9.6
484;hydroxyzine;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.7
145;icatibant;B1 receptor;Human;FALSE;Antagonist;Antagonist;6.4 - 7.0
147;icatibant;B2 receptor;Human;TRUE;Antagonist;Antagonist;10.2
559;iloperidone;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;7.0
626;iloperidone;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;7.2
639;iloperidone;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;7.0
806;iloprost;DP1 receptor;Human;FALSE;Agonist;Full agonist;6.0 - 6.6
807;iloprost;EP1 receptor;Human;FALSE;Agonist;Full agonist;5.6 - 8.0
810;iloprost;EP2 receptor;Human;FALSE;Agonist;Full agonist;5.7
813;iloprost;EP3 receptor;Human;FALSE;Agonist;Full agonist;6.7 - 7.3
816;iloprost;EP4 receptor;Human;FALSE;Agonist;Full agonist;4.6 - 6.7
819;iloprost;FP receptor;Human;FALSE;Agonist;Full agonist;6.2
821;iloprost;IP receptor;Human;TRUE;Agonist;Full agonist;7.5 - 8.0
823;iloprost;TP receptor;Human;FALSE;Agonist;Full agonist;5.2
72;imipramine;M2 receptor;Human;FALSE;Antagonist;Antagonist;6.9
411;indacaterol;beta1-adrenoceptor;Human;FALSE;Agonist;Agonist;6.7
415;indacaterol;beta2-adrenoceptor;Human;TRUE;Agonist;Agonist;7.8
216;indomethacin;DP2 receptor;Human;FALSE;Agonist;Full agonist;6.1 - 7.7
371;indoramin;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.4
377;indoramin;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
384;indoramin;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.7
66;ipratropium;M1 receptor;Human;FALSE;Antagonist;Antagonist;9.3
71;ipratropium;M2 receptor;Human;FALSE;Antagonist;Antagonist;8.8
77;ipratropium;M3 receptor;Human;TRUE;Antagonist;Antagonist;9.3 - 9.8
81;ipratropium;M4 receptor;Human;FALSE;Antagonist;Antagonist;9.2
85;ipratropium;M5 receptor;Human;FALSE;Antagonist;Antagonist;8.8
412;isoprenaline;beta1-adrenoceptor;Human;TRUE;Agonist;Full agonist;6.6 - 7.0
417;isoprenaline;beta2-adrenoceptor;Human;TRUE;Agonist;Full agonist;6.4
422;isoprenaline;beta3-adrenoceptor;Human;FALSE;Agonist;Full agonist;5.1 - 6.2
352;istradefylline;A1 receptor;Human;FALSE;Antagonist;Antagonist;6.1
357;istradefylline;A2A receptor;Human;FALSE;Antagonist;Antagonist;7.0 - 7.9
361;istradefylline;A2B receptor;Human;FALSE;Antagonist;Antagonist;5.0
365;istradefylline;A3 receptor;Human;FALSE;Antagonist;Antagonist;5.3
239;ketanserin;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;5.0
247;ketanserin;5-HT1B receptor;Mouse;FALSE;Antagonist;Antagonist;8.3
255;ketanserin;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;7.4 - 7.5
266;ketanserin;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;8.1 - 9.7
281;ketanserin;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;6.1 - 6.7
286;ketanserin;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;6.8 - 7.5
292;ketanserin;5-HT5A receptor;Human;FALSE;Antagonist;Antagonist;4.7
306;ketanserin;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;5.9 - 6.5
370;ketanserin;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.2
376;ketanserin;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.2
383;ketanserin;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.8
432;ketanserin;D1 receptor;Human;FALSE;Antagonist;Antagonist;6.7
468;ketanserin;D5 receptor;Human;FALSE;Antagonist;Antagonist;5.6
188;ketotifen;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.6
709;labetalol;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.6
725;labetalol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.2
729;labetalol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.0
532;lanreotide;SST2 receptor;Human;TRUE;Agonist;Full agonist;8.7 - 9.6
535;lanreotide;SST3 receptor;Human;FALSE;Agonist;Full agonist;7.2 - 8.0
537;lanreotide;SST5 receptor;Human;TRUE;Agonist;Full agonist;7.4 - 9.3
820;latanoprost (free acid form);FP receptor;Human;TRUE;Agonist;Full agonist;8.6
527;latanoprost (isopropyl ester);FP receptor;Human;TRUE;Agonist;Full agonist;6.3
818;latanoprostene bunod;FP receptor;Human;FALSE;Agonist;Agonist;8.6
778;leuprolide;GnRH1 receptor;Human;TRUE;Agonist;Full agonist;8.5 - 9.1
504;levallorphan;mu receptor;Human;TRUE;Antagonist;Antagonist;8.8 - 9.3
726;levobetaxolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.1
730;levobetaxolol;beta2-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.5
128;levobunolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.4
136;levobunolol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.3
140;levobunolol;beta3-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.8
795;levocabastine;NTS2 receptor;Human;FALSE;Agonist;Full agonist;6.8
1059;levosalbutamol;beta2-adrenoceptor;Human;FALSE;Agonist;Partial agonist;5.3
551;lisuride;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;9.7 - 9.8
566;lisuride;5-HT1B receptor;Human;FALSE;Agonist;Partial agonist;7.7
573;lisuride;5-HT1D receptor;Human;FALSE;Agonist;Partial agonist;9.0
588;lisuride;5-HT2A receptor;Human;FALSE;Agonist;Partial agonist;8.6
603;lisuride;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;8.9
608;lisuride;5-HT2C receptor;Human;FALSE;Agonist;Partial agonist;7.9 - 8.3
622;lisuride;5-HT6 receptor;Human;FALSE;Agonist;Partial agonist;8.0 - 8.1
635;lisuride;5-HT7 receptor;Rat;FALSE;Agonist;Full agonist;8.2 - 9.3
701;lisuride;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.3
713;lisuride;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;10.3
717;lisuride;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;9.9
722;lisuride;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;9.9
735;lisuride;D1 receptor;Human;FALSE;Agonist;Partial agonist;7.2
740;lisuride;D2 receptor;Human;FALSE;Agonist;Partial agonist;9.2 - 9.5
755;lisuride;D3 receptor;Human;FALSE;Agonist;Partial agonist;9.6
765;lisuride;D4 receptor;Human;FALSE;Agonist;Partial agonist;8.3
774;lisuride;D5 receptor;Human;FALSE;Agonist;Partial agonist;8.5
1110;lixisenatide;GLP-1 receptor;Human;TRUE;Agonist;Agonist;8.9
710;lofexidine;alpha2A-adrenoceptor;Human;FALSE;Agonist;Agonist;8.4
714;lofexidine;alpha2B-adrenoceptor;Human;FALSE;Agonist;Agonist;7.2
719;lofexidine;alpha2C-adrenoceptor;Human;FALSE;Agonist;Agonist;7.2
212;loperamide;mu receptor;Human;TRUE;Agonist;Agonist;9.3
1127;loratadine;H1 receptor;Human;TRUE;Antagonist;Antagonist;7.4
1019;lorazepam;alpha1B-adrenoceptor;Rat;FALSE;Allosteric modulator;Positive;3.8
586;lorcaserin;5-HT2A receptor;Human;FALSE;Agonist;Full agonist;6.8
600;lorcaserin;5-HT2B receptor;Human;FALSE;Agonist;Full agonist;6.8
606;lorcaserin;5-HT2C receptor;Human;FALSE;Agonist;Full agonist;7.8
275;loxapine;5-HT2A receptor;Human;TRUE;Antagonist;Inverse agonist;8.1
290;loxapine;5-HT2C receptor;Human;TRUE;Antagonist;Inverse agonist;7.8 - 8.0
300;loxapine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;7.4 - 7.6
311;loxapine;5-HT7 receptor;Rat;FALSE;Antagonist;Antagonist;6.8 - 7.4
442;loxapine;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.9 - 8.3
453;loxapine;D3 receptor;Human;TRUE;Antagonist;Antagonist;7.7
462;loxapine;D4 receptor;Human;TRUE;Antagonist;Antagonist;8.1
481;loxapine;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.2
854;lurasidone;5-HT1A receptor;Rat;FALSE;Agonist;Partial agonist;8.2
915;lurasidone;5-HT2A receptor;Rat;FALSE;Antagonist;Antagonist;8.7
969;lurasidone;5-HT7 receptor;Human;TRUE;Antagonist;Antagonist;9.3
1039;lurasidone;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
1049;lurasidone;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.0
1094;lurasidone;D2 receptor;Rat;FALSE;Antagonist;Antagonist;8.8
351;mefloquine;A1 receptor;Human;FALSE;Antagonist;Antagonist;6.2
356;mefloquine;A2A receptor;Human;FALSE;Antagonist;Antagonist;7.0
924;melatonin;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;5.2
1129;melatonin;MT1 receptor;Human;TRUE;Agonist;Full agonist;9.1 - 9.7
1130;melatonin;MT2 receptor;Human;TRUE;Agonist;Full agonist;9.4 - 9.8
191;mepyramine;H1 receptor;Human;TRUE;Antagonist;Inverse agonist;8.7 - 9.0
860;mesoridazine;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;7.0
907;mesoridazine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;7.3
933;mesoridazine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;6.4
1079;mesoridazine;D1 receptor;Human;FALSE;Antagonist;Antagonist;7.0
1089;mesoridazine;D2 receptor;Human;FALSE;Antagonist;Antagonist;8.7
1099;mesoridazine;D3 receptor;Human;FALSE;Antagonist;Antagonist;7.6
663;methacholine;M2 receptor;Rat;FALSE;Agonist;Agonist;7.2
682;methacholine;M4 receptor;Rat;FALSE;Agonist;Agonist;5.8
700;methoxamine;alpha1A-adrenoceptor;Human;TRUE;Agonist;Full agonist;5.0 - 5.2
703;methoxamine;alpha1B-adrenoceptor;Human;FALSE;Agonist;Full agonist;4.0
706;methoxamine;alpha1D-adrenoceptor;Human;FALSE;Agonist;Full agonist;4.9
885;methylergonovine;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;7.0 - 7.2
891;methylergonovine;5-HT1F receptor;Human;FALSE;Antagonist;Antagonist;7.5
894;methylergonovine;5-HT2A receptor;Human;FALSE;Agonist;Full agonist;9.4
918;methylergonovine;5-HT2B receptor;Human;FALSE;Agonist;Partial agonist;9.3
928;methylergonovine;5-HT2C receptor;Human;FALSE;Agonist;Full agonist;8.3
798;methylnaltrexone;delta receptor;Human;FALSE;Antagonist;Antagonist;6.1
802;methylnaltrexone;kappa receptor;Human;FALSE;Antagonist;Antagonist;8.2
805;methylnaltrexone;mu receptor;Human;TRUE;Antagonist;Antagonist;8.7
6;methysergide;5-HT1B receptor;Human;FALSE;Antagonist;Antagonist;6.6 - 7.6
11;methysergide;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;8.4 - 8.9
14;methysergide;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;6.5 - 6.8
17;methysergide;5-HT1F receptor;Human;FALSE;Antagonist;Antagonist;8.2
23;methysergide;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;8.4
29;methysergide;5-HT2B receptor;Human;TRUE;Agonist;Partial agonist;8.0 - 9.4
39;methysergide;5-HT2C receptor;Human;TRUE;Antagonist;Antagonist;8.6 - 9.1
45;methysergide;5-HT5A receptor;Human;FALSE;Antagonist;Antagonist;7.0
53;methysergide;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;6.5 - 6.8
59;methysergide;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;7.1 - 7.8
44;metoclopramide;5-HT4 receptor;Mouse;TRUE;Agonist;Full agonist;6.0
163;metoclopramide;D2 receptor;Mouse;TRUE;Antagonist;Antagonist;7.5
127;metoprolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;7.0 - 7.6
133;metoprolol;beta2-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.3
870;mianserin;5-HT1B receptor;Mouse;FALSE;Antagonist;Antagonist;8.3
904;mianserin;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.7 - 9.6
921;mianserin;5-HT2B receptor;Human;TRUE;Antagonist;Antagonist;7.9 - 8.8
940;mianserin;5-HT2C receptor;Human;TRUE;Antagonist;Inverse agonist;8.3 - 9.2
950;mianserin;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;6.9 - 7.3
966;mianserin;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;7.3 - 7.6
1013;mianserin;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.6
1021;mianserin;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
1030;mianserin;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.5
704;midazolam;alpha1B-adrenoceptor;Rat;FALSE;Allosteric modulator;Positive;3.7
832;midazolam;TRH1 receptor;Rat;FALSE;Antagonist;Antagonist;5.5
908;mirtazapine;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.2
934;mirtazapine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;7.4
1038;mirtazapine;alpha2A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;7.7
1048;mirtazapine;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.7
1168;misoprostol (methyl ester);EP2 receptor;Human;FALSE;Agonist;Full agonist;5.0
1172;misoprostol (methyl ester);EP3 receptor;Human;TRUE;Agonist;Full agonist;6.5
1178;misoprostol (methyl ester);EP4 receptor;Human;FALSE;Agonist;Full agonist;5.3
1128;mizolastine;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.6
905;molindone;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;6.5
1120;molindone;H1 receptor;Human;FALSE;Antagonist;Antagonist;5.7
791;montelukast;CysLT1 receptor;Human;TRUE;Antagonist;Antagonist;8.6
1134;morphine;delta receptor;Human;FALSE;Agonist;Full agonist;6.9
1141;morphine;kappa receptor;Human;FALSE;Agonist;Partial agonist;7.3
1151;morphine;mu receptor;Human;TRUE;Agonist;Full agonist;9.0
941;mosapride;5-HT4 receptor;Human;FALSE;Agonist;Full agonist;6.2 - 6.9
979;N-methyl scopolamine;M1 receptor;Human;TRUE;Antagonist;Antagonist;9.9
992;N-methyl scopolamine;M3 receptor;Human;TRUE;Antagonist;Antagonist;10.4
731;nabilone;CB1 receptor;Human;FALSE;Agonist;Agonist;8.4
732;nabilone;CB2 receptor;Human;FALSE;Agonist;Agonist;8.2
1054;nadolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.9
1062;nadolol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;7.0 - 8.6
1070;nadolol;beta3-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.3
495;nalbuphine;delta receptor;Human;TRUE;Agonist;Agonist;6.2
499;nalbuphine;kappa receptor;Human;TRUE;Agonist;Full agonist;7.4 - 7.5
501;nalbuphine;mu receptor;Human;TRUE;Agonist;Agonist;8.8
497;naldemedine;delta receptor;Human;FALSE;Antagonist;Antagonist;9.0
505;naldemedine;mu receptor;Human;TRUE;Antagonist;Antagonist;8.9
796;nalmefene;delta receptor;Human;FALSE;Agonist;Partial agonist;8.1
800;nalmefene;kappa receptor;Human;TRUE;Antagonist;Antagonist;9.5
803;nalmefene;mu receptor;Human;TRUE;Antagonist;Antagonist;9.5
207;nalorphine;delta receptor;Human;FALSE;Agonist;Partial agonist;7.4
210;nalorphine;kappa receptor;Human;FALSE;Agonist;Partial agonist;7.9 - 9.1
215;nalorphine;mu receptor;Human;TRUE;Antagonist;Antagonist;8.9
1135;naloxone;delta receptor;Human;TRUE;Antagonist;Antagonist;7.2
1143;naloxone;kappa receptor;Human;TRUE;Antagonist;Antagonist;7.6 - 8.6
1158;naloxone;mu receptor;Human;FALSE;Antagonist;Antagonist;8.9
797;naltrexone;delta receptor;Human;TRUE;Antagonist;Antagonist;8.0
801;naltrexone;kappa receptor;Human;TRUE;Antagonist;Antagonist;8.4 - 9.4
804;naltrexone;mu receptor;Human;TRUE;Antagonist;Antagonist;9.1 - 9.7
235;naratriptan;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;7.1 - 7.6
245;naratriptan;5-HT1B receptor;Human;TRUE;Agonist;Partial agonist;8.1
251;naratriptan;5-HT1D receptor;Human;TRUE;Agonist;Full agonist;8.4 - 9.0
258;naratriptan;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;7.7
261;naratriptan;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;8.2
27;nefazodone;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;8.2
1192;netupitant;NK1 receptor;Human;FALSE;Antagonist;Antagonist;9.0
95;nicardipine;A3 receptor;Human;FALSE;Antagonist;Antagonist;5.5
1011;noradrenaline;alpha1A-adrenoceptor;Human;FALSE;Agonist;Full agonist;5.8 - 6.4
1018;noradrenaline;alpha1B-adrenoceptor;Human;FALSE;Agonist;Full agonist;6.2
1025;noradrenaline;alpha1D-adrenoceptor;Human;FALSE;Agonist;Full agonist;7.4
1034;noradrenaline;alpha2A-adrenoceptor;Human;FALSE;Agonist;Full agonist;5.6 - 7.4
1041;noradrenaline;alpha2B-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.4 - 6.0
1044;noradrenaline;alpha2C-adrenoceptor;Human;TRUE;Agonist;Full agonist;5.7 - 6.8
1050;noradrenaline;beta1-adrenoceptor;Human;FALSE;Agonist;Agonist;5.5 - 6.0
1057;noradrenaline;beta2-adrenoceptor;Human;FALSE;Agonist;Agonist;4.6 - 4.8
1064;noradrenaline;beta3-adrenoceptor;Human;FALSE;Agonist;Full agonist;4.7 - 6.3
824;octreotide;SST2 receptor;Human;FALSE;Agonist;Full agonist;8.7 - 9.9
827;octreotide;SST3 receptor;Human;FALSE;Agonist;Full agonist;7.4 - 8.6
829;octreotide;SST5 receptor;Human;FALSE;Agonist;Full agonist;7.2 - 9.5
1;olanzapine;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;5.6 - 5.8
3;olanzapine;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;6.3
8;olanzapine;5-HT1D receptor;Human;FALSE;Agonist;Full agonist;6.2
12;olanzapine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;5.7
15;olanzapine;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;6.5
22;olanzapine;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;8.6 - 8.9
43;olanzapine;5-HT2C receptor;Human;TRUE;Antagonist;Inverse agonist;8.1 - 8.4
56;olanzapine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;8.0
58;olanzapine;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;6.5
158;olanzapine;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.7
183;olanzapine;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.7 - 9.2
67;oxybutynin;M1 receptor;Human;TRUE;Antagonist;Antagonist;8.6
73;oxybutynin;M2 receptor;Human;FALSE;Antagonist;Antagonist;7.7 - 8.1
74;oxybutynin;M2 receptor;Human;FALSE;Antagonist;Inverse agonist;7.9
78;oxybutynin;M3 receptor;Human;TRUE;Antagonist;Antagonist;8.8 - 8.9
82;oxybutynin;M4 receptor;Human;FALSE;Antagonist;Antagonist;8.7
86;oxybutynin;M5 receptor;Human;FALSE;Antagonist;Antagonist;7.9
4;oxymetazoline;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;9.5
10;oxymetazoline;5-HT1D receptor;Human;FALSE;Agonist;Partial agonist;9.4
34;oxymetazoline;5-HT2C receptor;Human;FALSE;Agonist;Full agonist;6.3 - 6.8
97;oxymetazoline;alpha1A-adrenoceptor;Human;TRUE;Agonist;Full agonist;8.0 - 8.2
102;oxymetazoline;alpha1B-adrenoceptor;Human;FALSE;Agonist;Full agonist;6.5
107;oxymetazoline;alpha1D-adrenoceptor;Human;FALSE;Agonist;Partial agonist;6.4
112;oxymetazoline;alpha2A-adrenoceptor;Human;TRUE;Agonist;Partial agonist;8.0 - 8.6
117;oxymetazoline;alpha2B-adrenoceptor;Human;FALSE;Agonist;Partial agonist;5.5 - 6.2
122;oxymetazoline;alpha2C-adrenoceptor;Human;FALSE;Agonist;Partial agonist;6.7
228;oxytocin;OT receptor;Human;TRUE;Agonist;Full agonist;8.2 - 9.6
224;oxytocin;V1A receptor;Human;FALSE;Agonist;Full agonist;6.9 - 8.3
226;oxytocin;V1B receptor;Human;FALSE;Agonist;Full agonist;5.7 - 7.0
227;oxytocin;V2 receptor;Human;FALSE;Agonist;Full agonist;5.4 - 6.8
206;pentazocine;delta receptor;Human;FALSE;Agonist;Full agonist;7.3
209;pentazocine;kappa receptor;Human;FALSE;Agonist;Partial agonist;7.8 - 8.6
214;pentazocine;mu receptor;Human;FALSE;Agonist;Partial agonist;8.4
1008;pentoxifylline;A2B receptor;Human;FALSE;Antagonist;Antagonist;5.3
237;pergolide;5-HT1A receptor;Human;FALSE;Agonist;Partial agonist;8.7
244;pergolide;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;6.6
254;pergolide;5-HT1D receptor;Human;FALSE;Agonist;Partial agonist;7.9
264;pergolide;5-HT2A receptor;Human;FALSE;Agonist;Full agonist;8.1
279;pergolide;5-HT2B receptor;Human;FALSE;Agonist;Full agonist;8.2
284;pergolide;5-HT2C receptor;Human;FALSE;Agonist;Partial agonist;6.5
294;pergolide;5-HT6 receptor;Rat;FALSE;Agonist;Full agonist;7.5
305;pergolide;5-HT7 receptor;Rat;FALSE;Agonist;Full agonist;8.3 - 9.0
390;pergolide;alpha2A-adrenoceptor;Human;FALSE;Agonist;Partial agonist;7.3
396;pergolide;alpha2B-adrenoceptor;Human;FALSE;Agonist;Partial agonist;7.5
404;pergolide;alpha2C-adrenoceptor;Human;FALSE;Agonist;Partial agonist;7.2
429;pergolide;D1 receptor;Human;FALSE;Agonist;Full agonist;5.9 - 6.5
436;pergolide;D2 receptor;Human;FALSE;Agonist;Full agonist;7.5 - 7.6
450;pergolide;D3 receptor;Human;FALSE;Agonist;Partial agonist;8.3
459;pergolide;D4 receptor;Human;FALSE;Agonist;Partial agonist;7.2
465;pergolide;D5 receptor;Human;FALSE;Agonist;Full agonist;6.0 - 7.5
1080;periciazine;D1 receptor;Human;FALSE;Antagonist;Antagonist;8.0
598;perospirone;5-HT2A receptor;Rat;FALSE;Antagonist;Antagonist;4.7
750;perospirone;D2 receptor;Human;TRUE;Antagonist;Antagonist;9.2
762;perospirone;D3 receptor;Human;TRUE;Antagonist;Antagonist;9.6
771;perospirone;D4 receptor;Human;TRUE;Antagonist;Antagonist;10.1
594;perphenazine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;8.2
610;perphenazine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;6.9
631;perphenazine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;7.1
648;perphenazine;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;7.2
747;perphenazine;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.9 - 9.6
785;perphenazine;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.1
1161;PGE1;DP1 receptor;Human;FALSE;Agonist;Full agonist;7.3
1163;PGE1;EP1 receptor;Human;TRUE;Agonist;Full agonist;6.8
1167;PGE1;EP2 receptor;Human;FALSE;Agonist;Full agonist;8.0
1174;PGE1;EP3 receptor;Mouse;FALSE;Agonist;Full agonist;9.0
1175;PGE1;EP3 receptor;Rat;FALSE;Agonist;Full agonist;9.0
1177;PGE1;EP4 receptor;Human;FALSE;Agonist;Full agonist;8.8
1181;PGE1;IP receptor;Human;FALSE;Agonist;Full agonist;6.5 - 6.8
511;PGE2;DP1 receptor;Human;FALSE;Agonist;Full agonist;6.5 - 7.0
512;PGE2;DP2 receptor;Human;FALSE;Agonist;Full agonist;5.3
514;PGE2;EP1 receptor;Human;FALSE;Agonist;Full agonist;7.3 - 8.0
517;PGE2;EP2 receptor;Human;TRUE;Agonist;Full agonist;7.5 - 8.3
520;PGE2;EP3 receptor;Human;FALSE;Agonist;Full agonist;9.5
523;PGE2;EP4 receptor;Human;FALSE;Agonist;Full agonist;8.1 - 9.1
526;PGE2;FP receptor;Human;FALSE;Agonist;Full agonist;6.4 - 6.9
531;PGE2;TP receptor;Human;FALSE;Agonist;Full agonist;4.5
218;PGI2;EP1 receptor;Human;TRUE;Agonist;Full agonist;4.8
219;PGI2;EP4 receptor;Human;FALSE;Agonist;Full agonist;5.1
220;PGI2;IP receptor;Human;FALSE;Agonist;Agonist;7.8
120;phenoxybenzamine;alpha2B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.5
1016;phentolamine;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.6
1024;phentolamine;alpha1B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;7.5
1033;phentolamine;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Inverse agonist;8.2
1037;phentolamine;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.4
1043;phentolamine;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.2
1047;phentolamine;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.6 - 7.9
1010;phenylephrine;alpha1A-adrenoceptor;Human;TRUE;Agonist;Full agonist;5.2 - 5.4
1026;phenylephrine;alpha1D-adrenoceptor;Rat;FALSE;Agonist;Full agonist;5.9
64;pilocarpine;M1 receptor;Human;FALSE;Agonist;Partial agonist;5.1
70;pilocarpine;M2 receptor;Human;FALSE;Agonist;Partial agonist;4.9
76;pilocarpine;M3 receptor;Human;TRUE;Agonist;Partial agonist;5.1
80;pilocarpine;M4 receptor;Human;FALSE;Agonist;Partial agonist;5.2
84;pilocarpine;M5 receptor;Human;FALSE;Agonist;Partial agonist;5.0
599;pimavanserin;5-HT2A receptor;Human;TRUE;Antagonist;Inverse agonist;9.3
855;pimozide;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;6.8
901;pimozide;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.1 - 7.7
955;pimozide;5-HT6 receptor;Rat;FALSE;Antagonist;Antagonist;7.2
971;pimozide;5-HT7 receptor;Rat;FALSE;Antagonist;Antagonist;9.3
1086;pimozide;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.0 - 8.8
1096;pimozide;D3 receptor;Human;FALSE;Antagonist;Antagonist;7.0 - 8.6
1117;pimozide;H1 receptor;Human;FALSE;Antagonist;Antagonist;6.2
856;pindolol;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;8.1
893;pindolol;5-HT2A receptor;Human;FALSE;Agonist;Full agonist;5.0
902;pindolol;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;5.0
917;pindolol;5-HT2B receptor;Human;FALSE;Agonist;Full agonist;5.7
919;pindolol;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;5.7
1051;pindolol;beta1-adrenoceptor;Human;TRUE;Agonist;Partial agonist;9.3
1058;pindolol;beta2-adrenoceptor;Human;TRUE;Agonist;Partial agonist;9.4
1090;pipotiazine;D2 receptor;Human;TRUE;Antagonist;Antagonist;9.7
656;pirenzepine;M1 receptor;Human;TRUE;Antagonist;Antagonist;7.8 - 8.3
667;pirenzepine;M2 receptor;Human;FALSE;Antagonist;Antagonist;6.0 - 6.7
676;pirenzepine;M3 receptor;Human;FALSE;Antagonist;Antagonist;6.5 - 6.8
685;pirenzepine;M4 receptor;Human;FALSE;Antagonist;Antagonist;7.0 - 7.6
689;pirenzepine;M5 receptor;Human;FALSE;Antagonist;Antagonist;6.8 - 7.1
189;pitolisant;H1 receptor;Human;FALSE;Antagonist;Antagonist;5.8
193;pitolisant;H2 receptor;Human;FALSE;Antagonist;Antagonist;5.0
195;pitolisant;H3 receptor;Human;TRUE;Antagonist;Antagonist;8.1 - 8.6
196;pitolisant;H4 receptor;Human;FALSE;Antagonist;Antagonist;4.0
560;pizotifen;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;7.4
426;plerixafor;CXCR4;Human;FALSE;Antagonist;Antagonist;6.7
427;plerixafor;CXCR4;Human;TRUE;Antagonist;Antagonist;7.0
1055;practolol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.1 - 6.8
1109;pralmorelin;ghrelin receptor;Rat;FALSE;Agonist;Full agonist;9.3
155;pramipexole;D2 receptor;Human;TRUE;Agonist;Full agonist;5.1 - 7.4
167;pramipexole;D3 receptor;Human;TRUE;Agonist;Full agonist;8.4 - 8.7
792;pranlukast;CysLT1 receptor;Human;TRUE;Antagonist;Antagonist;7.1 - 8.8
372;prazosin;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Inverse agonist;9.0 - 9.9
378;prazosin;alpha1B-adrenoceptor;Human;TRUE;Antagonist;Inverse agonist;9.6 - 9.9
386;prazosin;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Inverse agonist;9.5 - 10.2
393;prazosin;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;5.3 - 6.5
400;prazosin;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.4 - 7.5
408;prazosin;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;6.7 - 8.0
737;prochlorperazine;D1 receptor;Human;FALSE;Antagonist;Antagonist;7.1
749;prochlorperazine;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.4
761;prochlorperazine;D3 receptor;Human;TRUE;Antagonist;Antagonist;8.4
770;prochlorperazine;D4 receptor;Human;FALSE;Antagonist;Antagonist;6.1
445;promazine;D2 receptor;Human;TRUE;Antagonist;Antagonist;6.5
455;promazine;D3 receptor;Human;TRUE;Antagonist;Antagonist;6.8
788;promethazine;H1 receptor;Human;TRUE;Antagonist;Antagonist;9.6
129;propafenone;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.7
137;propafenone;beta2-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
982;propantheline;M1 receptor;Human;TRUE;Antagonist;Antagonist;9.7
987;propantheline;M2 receptor;Human;TRUE;Antagonist;Antagonist;9.5
995;propantheline;M3 receptor;Human;TRUE;Antagonist;Antagonist;10.0
1000;propantheline;M4 receptor;Human;FALSE;Antagonist;Antagonist;10.2
134;propranolol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.1 - 9.5
139;propranolol;beta3-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.3 - 7.2
615;prucalopride;5-HT4 receptor;Human;FALSE;Agonist;Partial agonist;7.0 - 8.6
849;quetiapine;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;6.5 - 6.6
873;quetiapine;5-HT1D receptor;Human;FALSE;Agonist;Full agonist;5.7
879;quetiapine;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;5.9
887;quetiapine;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;5.6
892;quetiapine;5-HT2A receptor;Human;FALSE;Agonist;Full agonist;7.0
899;quetiapine;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;6.4 - 7.0
1084;quetiapine;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.2
1115;quetiapine;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.0 - 8.7
179;raloxifene;GPER;Human;FALSE;Agonist;Full agonist;7.0
793;ramelteon;MT1 receptor;Human;TRUE;Agonist;Full agonist;10.9
794;ramelteon;MT2 receptor;Human;TRUE;Agonist;Full agonist;10.0
192;ranitidine;H2 receptor;Human;TRUE;Antagonist;Antagonist;7.1
1005;regadenoson;A1 receptor;Human;FALSE;Agonist;Agonist;5.0
1006;regadenoson;A2A receptor;Human;TRUE;Agonist;Agonist;6.5
1007;regadenoson;A2B receptor;Human;FALSE;Agonist;Agonist;5.0
1009;regadenoson;A3 receptor;Human;FALSE;Agonist;Agonist;5.0
659;revefenacin;M1 receptor;Human;FALSE;Antagonist;Antagonist;9.4
669;revefenacin;M2 receptor;Human;FALSE;Antagonist;Antagonist;9.5
679;revefenacin;M3 receptor;Human;FALSE;Antagonist;Antagonist;9.8
686;revefenacin;M4 receptor;Human;FALSE;Antagonist;Antagonist;9.3
690;revefenacin;M5 receptor;Human;FALSE;Antagonist;Antagonist;8.2
1075;rimonabant;CB1 receptor;Human;FALSE;Antagonist;Antagonist;7.9 - 8.7
857;risperidone;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;6.4 - 6.5
867;risperidone;5-HT1B receptor;Human;TRUE;Antagonist;Antagonist;6.6 - 7.3
876;risperidone;5-HT1D receptor;Human;TRUE;Antagonist;Antagonist;7.8 - 8.0
883;risperidone;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;5.9
889;risperidone;5-HT1F receptor;Human;FALSE;Antagonist;Antagonist;5.9
916;risperidone;5-HT2A receptor;Human;TRUE;Antagonist;Inverse agonist;9.3 - 10.0
939;risperidone;5-HT2C receptor;Human;FALSE;Antagonist;Inverse agonist;7.5 - 7.6
949;risperidone;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;5.6
976;risperidone;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;8.3 - 8.7
1012;risperidone;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.4
1020;risperidone;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.0
1029;risperidone;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.4
1087;risperidone;D2 receptor;Human;TRUE;Antagonist;Antagonist;9.4
1097;risperidone;D3 receptor;Human;FALSE;Antagonist;Antagonist;7.0
1118;risperidone;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.6 - 7.8
850;rizatriptan;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;6.4
865;rizatriptan;5-HT1B receptor;Human;TRUE;Agonist;Partial agonist;6.9
874;rizatriptan;5-HT1D receptor;Human;TRUE;Agonist;Full agonist;7.9
880;rizatriptan;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;6.8
888;rizatriptan;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;6.4 - 6.8
540;rolapitant;NK1 receptor;Human;FALSE;Antagonist;Antagonist;9.2
153;ropinirole;D2 receptor;Human;TRUE;Agonist;Agonist;8.1
165;ropinirole;D3 receptor;Human;TRUE;Agonist;Agonist;7.7
151;rotigotine;D1 receptor;Human;FALSE;Agonist;Full agonist;5.6
152;rotigotine;D2 receptor;Human;TRUE;Agonist;Agonist;10.2
164;rotigotine;D3 receptor;Human;FALSE;Agonist;Agonist;8.4
171;rotigotine;D4 receptor;Human;FALSE;Agonist;Agonist;7.3
177;rotigotine;D5 receptor;Human;FALSE;Agonist;Full agonist;6.0
486;rupatadine;H1 receptor;Guinea pig;FALSE;Antagonist;Antagonist;7.0
510;rupatadine;PAF receptor;Human;FALSE;Antagonist;Antagonist;5.4
418;salbutamol;beta2-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.8 - 6.1
906;sarpogrelate;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;8.5
923;sarpogrelate;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;6.6
932;sarpogrelate;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;7.4
321;scopolamine;M1 receptor;Human;TRUE;Antagonist;Antagonist;9.0
329;scopolamine;M2 receptor;Human;FALSE;Antagonist;Antagonist;8.7
336;scopolamine;M3 receptor;Human;FALSE;Antagonist;Antagonist;9.4
342;scopolamine;M4 receptor;Human;FALSE;Antagonist;Antagonist;9.5
529;selexipag;IP receptor;Human;FALSE;Agonist;Agonist;6.6
561;sertindole;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;6.4 - 6.6
568;sertindole;5-HT1B receptor;Human;FALSE;Antagonist;Antagonist;7.0
576;sertindole;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;7.2
581;sertindole;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;6.4
585;sertindole;5-HT1F receptor;Human;FALSE;Antagonist;Antagonist;6.4
592;sertindole;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;9.2 - 9.4
613;sertindole;5-HT2C receptor;Human;TRUE;Antagonist;Inverse agonist;9.0 - 9.2
745;sertindole;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.0 - 8.9
758;sertindole;D3 receptor;Human;TRUE;Antagonist;Antagonist;8.0 - 8.8
768;sertindole;D4 receptor;Human;TRUE;Antagonist;Antagonist;7.8 - 9.1
783;sertindole;H1 receptor;Human;FALSE;Antagonist;Antagonist;6.9
1015;silodosin;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;10.4
1023;silodosin;alpha1B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;7.7
1032;silodosin;alpha1D-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.7
323;solifenacin;M1 receptor;Human;FALSE;Antagonist;Antagonist;7.6
332;solifenacin;M2 receptor;Human;FALSE;Antagonist;Antagonist;6.9 - 7.1
339;solifenacin;M3 receptor;Human;FALSE;Antagonist;Antagonist;7.7 - 8.0
344;solifenacin;M4 receptor;Human;FALSE;Antagonist;Antagonist;6.8
348;solifenacin;M5 receptor;Human;FALSE;Antagonist;Antagonist;7.2
472;sonidegib;SMO;Human;TRUE;Antagonist;Antagonist;8.2
130;sotalol;beta1-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.1
138;sotalol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.5
1153;sufentanil;mu receptor;Human;TRUE;Agonist;Full agonist;9.9
160;sulpiride;D2 receptor;Human;TRUE;Antagonist;Antagonist;6.3 - 8.0
748;sulpiride;D2 receptor;Human;TRUE;Antagonist;Antagonist;7.2 - 7.9
169;sulpiride;D3 receptor;Human;TRUE;Antagonist;Antagonist;6.7 - 7.7
760;sulpiride;D3 receptor;Human;FALSE;Antagonist;Antagonist;6.8 - 7.8
175;sulpiride;D4 receptor;Human;FALSE;Antagonist;Antagonist;5.7 - 7.7
552;sumatriptan;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;6.0
567;sumatriptan;5-HT1B receptor;Human;TRUE;Agonist;Partial agonist;6.5 - 8.1
570;sumatriptan;5-HT1D receptor;Human;TRUE;Agonist;Full agonist;8.0 - 8.7
578;sumatriptan;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;5.6 - 5.8
583;sumatriptan;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;7.2 - 7.9
619;sumatriptan;5-HT5A receptor;Human;FALSE;Agonist;Full agonist;5.3
625;sumatriptan;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;5.6
637;sumatriptan;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;5.7 - 6.0
508;suramin;P2Y1 receptor;Human;FALSE;Antagonist;Antagonist;5.3
506;suvorexant;OX1 receptor;Human;TRUE;Antagonist;Antagonist;8.7 - 9.3
507;suvorexant;OX2 receptor;Human;TRUE;Antagonist;Antagonist;8.9 - 9.5
178;tamoxifen;GPER;Human;FALSE;Agonist;Full agonist;6.0
99;tamsulosin;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;10.0 - 10.7
105;tamsulosin;alpha1B-adrenoceptor;Human;TRUE;Antagonist;Inverse agonist;9.5 - 9.7
109;tamsulosin;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.8 - 10.2
213;tapentadol;mu receptor;Human;TRUE;Agonist;Agonist;6.8
203;tasimelteon;MT1 receptor;Human;TRUE;Agonist;Full agonist;9.5
205;tasimelteon;MT2 receptor;Human;TRUE;Agonist;Full agonist;10.2
925;tegaserod;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;8.4
943;tegaserod;5-HT4 receptor;Human;FALSE;Agonist;Partial agonist;7.6 - 8.4
101;terazosin;alpha1A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.7
104;terazosin;alpha1B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.6
111;terazosin;alpha1D-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.1
131;terbutaline;beta2-adrenoceptor;Human;TRUE;Agonist;Partial agonist;5.6
1124;terfenadine;H1 receptor;Human;TRUE;Antagonist;Antagonist;7.4
2;terguride;5-HT1A receptor;Human;FALSE;Agonist;Partial agonist;8.5
5;terguride;5-HT1B receptor;Human;FALSE;Agonist;Partial agonist;6.6
9;terguride;5-HT1D receptor;Human;FALSE;Agonist;Partial agonist;7.8
18;terguride;5-HT2A receptor;Human;FALSE;Agonist;Partial agonist;8.3
32;terguride;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;8.2
38;terguride;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;7.3
98;terguride;alpha1A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.5
115;terguride;alpha2A-adrenoceptor;Human;FALSE;Antagonist;Antagonist;9.5
119;terguride;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;9.4
124;terguride;alpha2C-adrenoceptor;Human;FALSE;Antagonist;Antagonist;9.1
157;terguride;D2 receptor;Human;FALSE;Agonist;Partial agonist;9.1
159;terguride;D2 receptor;Human;FALSE;Antagonist;Antagonist;8.9
168;terguride;D3 receptor;Human;FALSE;Agonist;Partial agonist;9.0
174;terguride;D4 receptor;Human;FALSE;Antagonist;Antagonist;8.1
88;theophylline;A1 receptor;Human;FALSE;Antagonist;Antagonist;4.9 - 5.2
90;theophylline;A2A receptor;Human;TRUE;Antagonist;Antagonist;5.2 - 5.8
92;theophylline;A2B receptor;Human;TRUE;Antagonist;Antagonist;4.1 - 5.0
94;theophylline;A3 receptor;Human;FALSE;Antagonist;Antagonist;4.1 - 4.7
858;thioridazine;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;7.1
903;thioridazine;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.4 - 8.0
931;thioridazine;5-HT2C receptor;Human;TRUE;Antagonist;Antagonist;7.2 - 7.3
960;thioridazine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;7.2
977;thioridazine;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;7.1
1078;thioridazine;D1 receptor;Human;FALSE;Antagonist;Antagonist;7.0
1105;thioridazine;D5 receptor;Human;FALSE;Antagonist;Antagonist;5.6
1119;thioridazine;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.7
26;thiothixene;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.3
184;thiothixene;H1 receptor;Human;FALSE;Antagonist;Antagonist;8.4
509;ticagrelor;P2Y12 receptor;Human;TRUE;Antagonist;Antagonist;7.8 - 8.7
135;timolol;beta2-adrenoceptor;Human;TRUE;Antagonist;Antagonist;9.7
657;tiotropium;M1 receptor;Human;FALSE;Antagonist;Antagonist;9.6
668;tiotropium;M2 receptor;Human;FALSE;Antagonist;Antagonist;9.9
678;tiotropium;M3 receptor;Human;TRUE;Antagonist;Antagonist;9.5 - 11.1
394;tolazoline;alpha2A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;6.7
401;tolazoline;alpha2B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;5.5
409;tolazoline;alpha2C-adrenoceptor;Human;TRUE;Antagonist;Antagonist;5.4
68;tolterodine;M1 receptor;Human;FALSE;Antagonist;Antagonist;8.5 - 8.7
75;tolterodine;M2 receptor;Human;FALSE;Antagonist;Inverse agonist;8.4 - 8.6
79;tolterodine;M3 receptor;Human;FALSE;Antagonist;Antagonist;8.4 - 8.5
83;tolterodine;M4 receptor;Human;FALSE;Antagonist;Antagonist;8.3 - 8.4
87;tolterodine;M5 receptor;Human;FALSE;Antagonist;Antagonist;8.5 - 8.8
542;tolvaptan;V1A receptor;Human;FALSE;Antagonist;Antagonist;7.9
546;tolvaptan;V2 receptor;Human;TRUE;Antagonist;Antagonist;9.4
547;tolvaptan;V2 receptor;Human;FALSE;Antagonist;Antagonist;9.4
1132;tramadol;delta receptor;Human;FALSE;Agonist;Agonist;8.0
1139;tramadol;kappa receptor;Human;FALSE;Agonist;Agonist;7.8
1148;tramadol;mu receptor;Human;FALSE;Agonist;Agonist;5.8
595;trazodone;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;7.4
605;trazodone;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;7.1
611;trazodone;5-HT2C receptor;Human;TRUE;Antagonist;Antagonist;6.6
1162;treprostinil;DP1 receptor;Human;FALSE;Agonist;Full agonist;8.4
1164;treprostinil;EP1 receptor;Human;FALSE;Agonist;Full agonist;6.7
1169;treprostinil;EP2 receptor;Human;FALSE;Agonist;Full agonist;8.4
1173;treprostinil;EP3 receptor;Human;FALSE;Agonist;Full agonist;5.6
1176;treprostinil;EP4 receptor;Human;FALSE;Agonist;Agonist;6.1
1182;treprostinil;IP receptor;Human;TRUE;Agonist;Full agonist;7.5
221;TRH;TRH1 receptor;Rat;TRUE;Agonist;Full agonist;7.4
230;TRH;TRH2 receptor;Rat;FALSE;Agonist;Full agonist;7.4
268;trifluoperazine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;7.9
287;trifluoperazine;5-HT2C receptor;Human;FALSE;Antagonist;Antagonist;6.4
443;trifluoperazine;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.9 - 9.0
463;trifluoperazine;D4 receptor;Human;FALSE;Antagonist;Antagonist;7.4
482;trifluoperazine;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.2
658;trihexyphenidyl;M1 receptor;Human;TRUE;Antagonist;Antagonist;8.9
1123;triprolidine;H1 receptor;Human;TRUE;Antagonist;Antagonist;8.5 - 9.0
474;triptorelin;GnRH1 receptor;Human;FALSE;Agonist;Full agonist;9.3 - 9.5
337;tropicamide;M3 receptor;Human;TRUE;Antagonist;Antagonist;7.5
616;tropisetron;5-HT4 receptor;Human;FALSE;Antagonist;Antagonist;6.3 - 7.1
322;umeclidinium;M1 receptor;Human;FALSE;Antagonist;Antagonist;9.8
331;umeclidinium;M2 receptor;Human;FALSE;Antagonist;Antagonist;9.8
338;umeclidinium;M3 receptor;Human;FALSE;Antagonist;Antagonist;10.2
343;umeclidinium;M4 receptor;Human;FALSE;Antagonist;Antagonist;10.3
347;umeclidinium;M5 receptor;Human;FALSE;Antagonist;Antagonist;9.9
1185;vapreotide;SST2 receptor;Human;TRUE;Agonist;Full agonist;8.3 - 10.1
1188;vapreotide;SST3 receptor;Human;TRUE;Agonist;Full agonist;7.4 - 7.9
1190;vapreotide;SST5 receptor;Human;TRUE;Agonist;Full agonist;7.3 - 9.2
846;vasopressin;OT receptor;Human;FALSE;Agonist;Partial agonist;7.3 - 9.3
834;vasopressin;V1A receptor;Human;TRUE;Agonist;Full agonist;8.5 - 9.3
838;vasopressin;V1B receptor;Human;TRUE;Agonist;Full agonist;9.0 - 9.5
842;vasopressin;V2 receptor;Human;TRUE;Agonist;Full agonist;7.9 - 9.1
556;vilazodone;5-HT1A receptor;Human;TRUE;Agonist;Partial agonist;9.7
777;vismodegib;SMO;Human;TRUE;Antagonist;Antagonist;7.8
1184;vorapaxar;PAR1;Human;TRUE;Antagonist;Antagonist;8.1
853;vortioxetine;5-HT1A receptor;Human;TRUE;Agonist;Partial agonist;7.8
866;vortioxetine;5-HT1B receptor;Human;TRUE;Agonist;Partial agonist;7.5
909;vortioxetine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;6.7
947;vortioxetine;5-HT5A receptor;Human;FALSE;Antagonist;Antagonist;6.7
953;vortioxetine;5-HT6 receptor;Human;FALSE;Antagonist;Antagonist;6.5
968;vortioxetine;5-HT7 receptor;Human;TRUE;Antagonist;Antagonist;6.3
1028;xylometazoline;alpha1D-adrenoceptor;Rat;FALSE;Agonist;Full agonist;6.0
859;yohimbine;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;7.3
868;yohimbine;5-HT1B receptor;Human;FALSE;Antagonist;Antagonist;6.8 - 7.6
877;yohimbine;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;7.2 - 7.7
884;yohimbine;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;5.9
890;yohimbine;5-HT1F receptor;Human;FALSE;Antagonist;Antagonist;7.0
920;yohimbine;5-HT2B receptor;Human;FALSE;Antagonist;Antagonist;7.4 - 7.9
946;yohimbine;5-HT5A receptor;Human;FALSE;Antagonist;Antagonist;5.3
965;yohimbine;5-HT7 receptor;Human;FALSE;Antagonist;Antagonist;5.6
1036;yohimbine;alpha2A-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.4 - 9.2
1042;yohimbine;alpha2B-adrenoceptor;Human;TRUE;Antagonist;Antagonist;7.9 - 8.9
1046;yohimbine;alpha2C-adrenoceptor;Human;TRUE;Antagonist;Antagonist;8.5 - 9.5
197;zafirlukast;CysLT1 receptor;Human;TRUE;Antagonist;Antagonist;8.9
852;ziprasidone;5-HT1A receptor;Human;FALSE;Agonist;Partial agonist;7.9 - 8.9
864;ziprasidone;5-HT1B receptor;Human;FALSE;Agonist;Full agonist;8.3
875;ziprasidone;5-HT1D receptor;Human;FALSE;Agonist;Full agonist;9.0
881;ziprasidone;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;6.4
900;ziprasidone;5-HT2A receptor;Human;TRUE;Antagonist;Antagonist;8.8 - 9.5
938;ziprasidone;5-HT2C receptor;Human;TRUE;Antagonist;Inverse agonist;7.9 - 9.0
975;ziprasidone;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;8.4
1085;ziprasidone;D2 receptor;Human;TRUE;Antagonist;Antagonist;8.6
1116;ziprasidone;H1 receptor;Human;FALSE;Antagonist;Antagonist;7.4 - 7.8
236;zolmitriptan;5-HT1A receptor;Human;FALSE;Agonist;Full agonist;6.6
246;zolmitriptan;5-HT1B receptor;Human;TRUE;Agonist;Partial agonist;7.7
252;zolmitriptan;5-HT1D receptor;Human;TRUE;Agonist;Full agonist;8.9
259;zolmitriptan;5-ht1e receptor;Human;FALSE;Agonist;Full agonist;7.7
262;zolmitriptan;5-HT1F receptor;Human;FALSE;Agonist;Full agonist;7.4 - 7.5
562;zotepine;5-HT1A receptor;Human;FALSE;Antagonist;Antagonist;6.5
569;zotepine;5-HT1B receptor;Human;FALSE;Antagonist;Antagonist;7.2
577;zotepine;5-HT1D receptor;Human;FALSE;Antagonist;Antagonist;9.3
582;zotepine;5-ht1e receptor;Human;FALSE;Antagonist;Antagonist;6.5
593;zotepine;5-HT2A receptor;Human;FALSE;Antagonist;Antagonist;8.6
614;zotepine;5-HT2C receptor;Human;FALSE;Antagonist;Inverse agonist;8.6
630;zotepine;5-HT6 receptor;Human;FALSE;Antagonist;Inverse agonist;8.3
647;zotepine;5-HT7 receptor;Human;FALSE;Antagonist;Inverse agonist;8.4
718;zotepine;alpha2B-adrenoceptor;Human;FALSE;Antagonist;Antagonist;8.2
746;zotepine;D2 receptor;Human;FALSE;Antagonist;Antagonist;8.0
759;zotepine;D3 receptor;Human;FALSE;Antagonist;Antagonist;8.2
769;zotepine;D4 receptor;Human;FALSE;Antagonist;Antagonist;7.4
784;zotepine;H1 receptor;Human;FALSE;Antagonist;Antagonist;9.2